Sandy Draper
Stock Analyst at Guggenheim
(2.92)
# 1,470
Out of 4,874 analysts
119
Total ratings
58.33%
Success rate
19.77%
Average return
Main Sectors:
Stocks Rated by Sandy Draper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MEDP Medpace Holdings | Maintains: Buy | $464 → $432 | $306.80 | +40.81% | 12 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Neutral | n/a | $158.16 | - | 8 | Feb 15, 2024 | |
| CRL Charles River Laboratories International | Downgrades: Neutral | n/a | $151.59 | - | 15 | Feb 15, 2024 | |
| EVH Evolent Health | Maintains: Hold | $36 → $34 | $10.75 | +216.28% | 9 | Nov 14, 2023 | |
| GDRX GoodRx Holdings | Maintains: Buy | $8 → $10 | $4.93 | +102.84% | 4 | Aug 10, 2023 | |
| DOCS Doximity | Downgrades: Neutral | n/a | $60.41 | - | 3 | Aug 9, 2023 | |
| TOI The Oncology Institute | Maintains: Buy | $3 → $2 | $2.24 | -10.71% | 3 | Jun 16, 2023 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $271 → $263 | $146.75 | +79.22% | 13 | Apr 28, 2023 | |
| AGL agilon health | Maintains: Buy | $21 → $30 | $2.31 | +1,198.70% | 3 | Mar 6, 2023 | |
| HQY HealthEquity | Maintains: Buy | $89 → $94 | $104.86 | -10.36% | 11 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $8.05 | - | 10 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $51 | $22.00 | +131.82% | 2 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $143 → $129 | $168.17 | -23.29% | 2 | May 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $55 | $26.81 | +105.15% | 2 | May 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $226 → $168 | $51.81 | +224.26% | 2 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $12 | $46.28 | -74.07% | 1 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $33 → $38 | $21.80 | +74.31% | 7 | Feb 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $6.37 | +684.93% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $7.16 | +807.82% | 1 | Jan 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $3.75 | +861.28% | 4 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $167 | $281.19 | -40.61% | 3 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.48 | - | 2 | May 31, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $63 | $18.44 | +241.65% | 1 | Sep 20, 2016 |
Medpace Holdings
Jul 24, 2024
Maintains: Buy
Price Target: $464 → $432
Current: $306.80
Upside: +40.81%
IQVIA Holdings
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $158.16
Upside: -
Charles River Laboratories International
Feb 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $151.59
Upside: -
Evolent Health
Nov 14, 2023
Maintains: Hold
Price Target: $36 → $34
Current: $10.75
Upside: +216.28%
GoodRx Holdings
Aug 10, 2023
Maintains: Buy
Price Target: $8 → $10
Current: $4.93
Upside: +102.84%
Doximity
Aug 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $60.41
Upside: -
The Oncology Institute
Jun 16, 2023
Maintains: Buy
Price Target: $3 → $2
Current: $2.24
Upside: -10.71%
ICON Public Limited Company
Apr 28, 2023
Maintains: Buy
Price Target: $271 → $263
Current: $146.75
Upside: +79.22%
agilon health
Mar 6, 2023
Maintains: Buy
Price Target: $21 → $30
Current: $2.31
Upside: +1,198.70%
HealthEquity
Dec 7, 2022
Maintains: Buy
Price Target: $89 → $94
Current: $104.86
Upside: -10.36%
Oct 24, 2022
Upgrades: Neutral
Price Target: n/a
Current: $8.05
Upside: -
Aug 12, 2022
Maintains: Buy
Price Target: $36 → $51
Current: $22.00
Upside: +131.82%
May 25, 2021
Maintains: Buy
Price Target: $143 → $129
Current: $168.17
Upside: -23.29%
May 18, 2021
Maintains: Buy
Price Target: $84 → $55
Current: $26.81
Upside: +105.15%
May 12, 2021
Maintains: Buy
Price Target: $226 → $168
Current: $51.81
Upside: +224.26%
Apr 21, 2021
Initiates: Hold
Price Target: $12
Current: $46.28
Upside: -74.07%
Feb 4, 2021
Maintains: Hold
Price Target: $33 → $38
Current: $21.80
Upside: +74.31%
Jan 28, 2021
Initiates: Buy
Price Target: $50
Current: $6.37
Upside: +684.93%
Jan 28, 2021
Initiates: Buy
Price Target: $65
Current: $7.16
Upside: +807.82%
May 13, 2020
Maintains: Buy
Price Target: $30 → $36
Current: $3.75
Upside: +861.28%
Mar 26, 2020
Maintains: Buy
Price Target: $175 → $167
Current: $281.19
Upside: -40.61%
May 31, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.48
Upside: -
Sep 20, 2016
Initiates: Buy
Price Target: $63
Current: $18.44
Upside: +241.65%